320 related articles for article (PubMed ID: 30983504)
1. The rs17084733 variant in the
Ravegnini G; Serrano C; Simeon V; Sammarini G; Nannini M; Roversi E; Urbini M; Ferrè F; Ricci R; Tarantino G; Pantaleo MA; Hrelia P; Angelini S
Epigenetics; 2019 Jun; 14(6):545-557. PubMed ID: 30983504
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
Kim WK; Park M; Kim YK; Tae YK; Yang HK; Lee JM; Kim H
Clin Cancer Res; 2011 Dec; 17(24):7584-94. PubMed ID: 22042971
[TBL] [Abstract][Full Text] [Related]
3. MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; van Ijcken WF; Wozniak A; Sciot R; Rutkowski P; Schöffski P; Taguchi T; Mathijssen RH; Verweij J; Sleijfer S; Debiec-Rychter M; Wiemer EA
Br J Cancer; 2013 Sep; 109(6):1625-35. PubMed ID: 23969726
[TBL] [Abstract][Full Text] [Related]
4. PIK3C2A is a gene-specific target of microRNA-518a-5p in imatinib mesylate-resistant gastrointestinal stromal tumor.
Shi Y; Gao X; Hu Q; Li X; Xu J; Lu S; Liu Y; Xu C; Jiang D; Lin J; Xue A; Tan Y; Shen K; Hou Y
Lab Invest; 2016 Jun; 96(6):652-60. PubMed ID: 26950487
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression.
Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK
Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025
[TBL] [Abstract][Full Text] [Related]
6. Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors.
Pantaleo MA; Ravegnini G; Astolfi A; Simeon V; Nannini M; Saponara M; Urbini M; Gatto L; Indio V; Sammarini G; Santini D; Ferracin M; Negrini M; Hrelia P; Biasco G; Angelini S
Epigenomics; 2016 Oct; 8(10):1347-1366. PubMed ID: 27625077
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor-mediated wild-type KIT receptor activation is critical for gastrointestinal stromal tumor cell growth.
Bai CG; Hou XW; Wang F; Qiu C; Zhu Y; Huang L; Zhao J; Xu JJ; Ma DL
World J Gastroenterol; 2012 Jun; 18(23):2929-37. PubMed ID: 22736916
[TBL] [Abstract][Full Text] [Related]
8. MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor.
Liu S; Cui J; Liao G; Zhang Y; Ye K; Lu T; Qi J; Wan G
Tumour Biol; 2014 Sep; 35(9):9131-8. PubMed ID: 25027394
[TBL] [Abstract][Full Text] [Related]
9. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis.
Wang K; Li J; Guo H; Xu X; Xiong G; Guan X; Liu B; Li J; Chen X; Yang K; Bai Y
Carcinogenesis; 2012 Nov; 33(11):2147-54. PubMed ID: 22859270
[TBL] [Abstract][Full Text] [Related]
10. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.
Fan R; Zhong J; Zheng S; Wang Z; Xu Y; Li S; Zhou J; Yuan F
Tumour Biol; 2014 May; 35(5):4209-17. PubMed ID: 24375253
[TBL] [Abstract][Full Text] [Related]
12. miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours.
Ihle MA; Trautmann M; Kuenstlinger H; Huss S; Heydt C; Fassunke J; Wardelmann E; Bauer S; Schildhaus HU; Buettner R; Merkelbach-Bruse S
Mol Oncol; 2015 Aug; 9(7):1421-33. PubMed ID: 25898773
[TBL] [Abstract][Full Text] [Related]
13. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).
Nannini M; Biasco G; Astolfi A; Pantaleo MA
J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252
[TBL] [Abstract][Full Text] [Related]
14. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
[TBL] [Abstract][Full Text] [Related]
15. RACK1 overexpression is linked to acquired imatinib resistance in gastrointestinal stromal tumor.
Gao X; Xue A; Fang Y; Shu P; Ling J; Hou Y; Shen K; Qin J; Sun Y; Qin X
Oncotarget; 2016 Mar; 7(12):14300-9. PubMed ID: 26893362
[TBL] [Abstract][Full Text] [Related]
16. KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome.
Brahmi M; Alberti L; Dufresne A; Ray-Coquard I; Cassier P; Meeus P; Decouvelaere AV; Ranchère-Vince D; Blay JY
BMC Cancer; 2015 Oct; 15():780. PubMed ID: 26498480
[TBL] [Abstract][Full Text] [Related]
17. The Relevance of SNPs at 3'UTR Region of CASP7 and miR-371b-5p Associated Diseases: A Computational Analysis.
Safdar M; Zaheer S; Khailany RA; Parvez S; Naveed M; Bhuiyan P; Ozaslan M; Moatasam R; Al-Attar MS; Khan MA; Junejo Y
Cell Biochem Biophys; 2020 Dec; 78(4):541-557. PubMed ID: 32951155
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome.
Ravegnini G; Nannini M; Simeon V; Musti M; Sammarini G; Saponara M; Gatto L; Urbini M; Astolfi A; Biasco G; Pantaleo MA; Venturoli N; Hrelia P; Angelini S
Tumour Biol; 2016 Oct; 37(10):13413-13423. PubMed ID: 27460091
[TBL] [Abstract][Full Text] [Related]
19. Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate.
Rausch JL; Boichuk S; Ali AA; Patil SS; Liu L; Lee DM; Brown MF; Makielski KR; Liu Y; Taguchi T; Kuan SF; Duensing A
Oncotarget; 2017 Jan; 8(3):4471-4483. PubMed ID: 27965460
[TBL] [Abstract][Full Text] [Related]
20. A Screen for Epigenetically Silenced microRNA Genes in Gastrointestinal Stromal Tumors.
Isosaka M; Niinuma T; Nojima M; Kai M; Yamamoto E; Maruyama R; Nobuoka T; Nishida T; Kanda T; Taguchi T; Hasegawa T; Tokino T; Hirata K; Suzuki H; Shinomura Y
PLoS One; 2015; 10(7):e0133754. PubMed ID: 26214687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
